GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Independence Bank of Kentucky

Independence Bank of Kentucky lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,018 shares of the company’s stock after acquiring an additional 114 shares during the quarter. Independence Bank of Kentucky’s holdings in GE HealthCare Technologies were worth $158,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. NewEdge Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 5.6% in the 2nd quarter. NewEdge Advisors LLC now owns 14,645 shares of the company’s stock valued at $1,141,000 after buying an additional 775 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in shares of GE HealthCare Technologies by 9.5% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 8,150 shares of the company’s stock valued at $636,000 after purchasing an additional 710 shares during the last quarter. Quarry LP raised its position in shares of GE HealthCare Technologies by 28.3% during the 2nd quarter. Quarry LP now owns 594 shares of the company’s stock worth $46,000 after purchasing an additional 131 shares during the period. Cetera Investment Advisers lifted its holdings in shares of GE HealthCare Technologies by 7.7% in the 2nd quarter. Cetera Investment Advisers now owns 73,713 shares of the company’s stock worth $5,744,000 after purchasing an additional 5,239 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter valued at approximately $1,382,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $88.30 on Monday. GE HealthCare Technologies Inc. has a 1 year low of $72.52 and a 1 year high of $94.55. The stock’s 50-day moving average price is $82.87 and its two-hundred day moving average price is $85.04. The company has a market cap of $40.34 billion, a PE ratio of 24.26, a PEG ratio of 2.90 and a beta of 1.11. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.16%. The ex-dividend date is Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the transaction, the chief executive officer now directly owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on GEHC. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.